)
AdaptHealth (AHCO) investor relations material
AdaptHealth UBS Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Capitated contracts and revenue outlook
Capitated contract with Humana renewed for five years, now covering 33 states, with potential for further expansion and new payer partnerships.
Capitated revenue is highly predictable, slow-moving, and tied to membership trends; slight decrease this year due to fewer members, but growth expected next year.
New large IDN contract expected to generate at least $1 billion over five years, requiring significant upfront investment in infrastructure and staff.
Revenue growth for next year projected at 6-8%, ramping through the year, with margin expansion expected in the second half as new contracts mature.
EBITDA margin anticipated at 20% and free cash flow margin between 6-7% of revenue, consistent with enterprise averages after initial ramp-up.
Operational improvements and technology investments
Standardization across regions has enabled rapid operational improvements, notably reducing average time to therapy in sleep from 23 to 10 days.
Focus on customer service and operational excellence has led to increased inbound interest from payers and hospital systems.
Technology deployment prioritized after standardizing processes, with digital tools and automation driving efficiency and reducing headcount.
Revenue cycle automation and AI are being implemented, with significant cost-saving opportunities as offshore headcount is reduced.
MyApp digital platform adoption is growing, supporting self-service and further reducing administrative burden.
Diabetes business and efficiency initiatives
Diabetes segment stabilized after operational restructuring, with resupply business centralized and sales force realigned.
Pharmacy order processing time reduced from 36 to 5 minutes through new SaaS technology, improving efficiency and potential profitability.
Diabetes revenue now represents 17-18% of total, expected to become a smaller share as other segments grow.
Investment decisions in diabetes are data-driven, focusing on profitability and service quality.
Next AdaptHealth earnings date
Next AdaptHealth earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage